Redesigning clinical trials in the era of precision medicine
4 Jul 2017
Redesigning clinical trials in the era of precision medicine
Synthetic lethality as a basis to select drug combinations
Proteogenomics in cancer research
EADO conference highlights
Theory and application of electrochemotherapy
Intralesional T-VEC and combinations for melanoma
Brain metastases: Gamma knife and new treatments
Essential regional control of skin cancers
New imaging approaches for the diagnosis of melanoma and skin cancer
Mutational landscapes in pregnant and non-pregnant breast cancer
Adaptive trial design on breast cancer
Identifying cancer in dense breast tissue